NIH-funded research R01 grant

Understanding how HPV infection affects oral cancer in HIV-positive individuals in Nigeria

Official title: Epigenetic study of oral HPV infection-associated oral cancer in people living with HIV in Nigeria

Funded at Northwestern University at Chicago · NIH-10913421 · Data updated 2026-11-12

This study is looking at how HPV infections might affect the risk of oral cancers in people living with HIV in Nigeria, and it hopes to find ways to help prevent and catch these cancers early by understanding changes in gene activity.

More Oral Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNorthwestern University at Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 16, 2022
Project endAugust 31, 2026
Funding year2024
Award (this year)$779,097
NIH project number5R01CA274952-03
Project IDNIH-10913421 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who are at risk for HPV infections and oral cancers.

Less likely to help

Patients who do not have HIV or those without HPV infections may not benefit from this research.

What this research studies

This research investigates the link between Human papillomavirus (HPV) infections and oral cancers in people living with HIV in Nigeria. It aims to identify how epigenetic changes, which are modifications in gene expression, can indicate the risk of developing these cancers. By studying the prevalence of HPV and its interaction with HIV, the research seeks to develop targeted interventions for better prevention and early detection of oral and oropharyngeal cancers. Patients may be involved in providing samples and data to help understand these relationships.

Why it matters

Potential benefit: If successful, this research could lead to improved prevention strategies and early detection methods for oral cancers in HIV-positive individuals.

How similar studies have gone: Previous research has shown promising results in understanding the relationship between HPV and cancer in similar populations, indicating that this approach has potential for success.

Where this research is happening

  • Northwestern University at Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Hou, Lifang — Northwestern University at Chicago
  • Study coordinator: Hou, Lifang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.